Annual Cash & Cash Equivalents
$57.42 M
-$10.76 M-15.78%
31 December 2023
Summary:
Mereo BioPharma annual cash & cash equivalents is currently $57.42 million, with the most recent change of -$10.76 million (-15.78%) on 31 December 2023. During the last 3 years, it has risen by +$25.44 million (+79.53%). MREO annual cash & cash equivalents is now -54.88% below its all-time high of $127.27 million, reached on 31 December 2021.MREO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$80.52 M
-$6.91 M-7.90%
30 September 2024
Summary:
Mereo BioPharma quarterly cash and cash equivalents is currently $80.52 million, with the most recent change of -$6.91 million (-7.90%) on 30 September 2024. MREO quarterly cash and cash equivalents is now -47.15% below its all-time high of $152.37 million, reached on 30 June 2021.MREO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.8% | - |
| 3 y3 years | +79.5% | -47.1% |
| 5 y5 years | +80.7% | +124.6% |
MREO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -54.9% | +79.5% | -47.1% | +65.5% |
| 5 y | 5 years | -54.9% | +167.9% | -47.1% | +275.7% |
| alltime | all time | -54.9% | +216.4% | -47.1% | +343.8% |
Mereo BioPharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $80.52 M(-7.9%) |
| June 2024 | - | $87.43 M(+79.7%) |
| Mar 2024 | - | $48.66 M(-15.3%) |
| Dec 2023 | $57.42 M(-15.8%) | $57.42 M(+8.1%) |
| June 2023 | - | $53.12 M(-22.1%) |
| Dec 2022 | $68.18 M(-46.4%) | $68.18 M(-26.4%) |
| June 2022 | - | $92.68 M(-27.2%) |
| Dec 2021 | $127.27 M(+297.9%) | $127.27 M(-16.5%) |
| June 2021 | - | $152.37 M(+376.4%) |
| Dec 2020 | $31.98 M | $31.98 M(-54.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $69.94 M(+226.3%) |
| Dec 2019 | $21.43 M(-32.5%) | $21.43 M(-40.2%) |
| June 2019 | - | $35.85 M(+12.8%) |
| Dec 2018 | $31.78 M(-53.0%) | $31.78 M(-29.4%) |
| June 2018 | - | $44.99 M(-33.5%) |
| Dec 2017 | $67.63 M(+2.3%) | $67.63 M(-0.2%) |
| June 2017 | - | $67.75 M(+2.5%) |
| Dec 2016 | $66.10 M(+264.3%) | $66.10 M(-29.4%) |
| June 2016 | - | $93.67 M(+416.2%) |
| Dec 2015 | $18.15 M | $18.15 M |
FAQ
- What is Mereo BioPharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Mereo BioPharma?
- What is Mereo BioPharma annual cash & cash equivalents year-on-year change?
- What is Mereo BioPharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Mereo BioPharma?
What is Mereo BioPharma annual cash & cash equivalents?
The current annual cash & cash equivalents of MREO is $57.42 M
What is the all time high annual cash & cash equivalents for Mereo BioPharma?
Mereo BioPharma all-time high annual cash & cash equivalents is $127.27 M
What is Mereo BioPharma annual cash & cash equivalents year-on-year change?
Over the past year, MREO annual cash & cash equivalents has changed by -$10.76 M (-15.78%)
What is Mereo BioPharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MREO is $80.52 M
What is the all time high quarterly cash and cash equivalents for Mereo BioPharma?
Mereo BioPharma all-time high quarterly cash and cash equivalents is $152.37 M